HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Regulatory Uniformity In U.S. Top Priority For ICMAD

This article was originally published in The Rose Sheet

Executive Summary

Small-business trade group the Independent Cosmetic Manufacturers and Distributors will continue advocating in 2014 for uniform cosmetics regulations throughout the United States, CEO Pam Busiek said in an interview with “The Rose Sheet.” ICMAD cites collaboration with other industry trade associations as a highlight of 2013.

You may also be interested in...



ICMAD Founder Urges Members To “Yell Loud” On Regulatory Issues

Herb Wilson, one of the founders of the Independent Cosmetic Manufacturers and Distributors, spoke during the ICMAD Annual Meeting June 11 in New York and issued a rallying cry for small businesses to speak up on the regulatory issues that impact them.

PCPC, FDA Negotiate Oversight Bill With Possible State-Law Preemption

While acknowledging that there is “a long, long way to go,” PCPC’s John Hurson says industry and FDA have reached a tentative framework for legislation that would update federal cosmetics regulations and possibly preempt state laws, which have become the bane of national cosmetics manufacturers.

Indie Brands “Make Big Brands Smarter” – L’Oreal Exec

At the Independent Cosmetic Manufacturers and Distributors annual meeting and CITY awards ceremony, guest speaker L’Oreal Luxe division President Carol Hamilton professed her love for indie brands and discussed their impact on L’Oreal.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019354

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel